B

Baroness Merron (Lab)

Speaking in the House of Lords on 22 October 2026

Debate

Hormone Replacement Therapy: Product Shortage

Contribution

I could not possibly comment. However, it is important to acknowledge that concern among women or any other group. It can be very distressing and worrying, and it is why we have taken all the actions that I have already described. I emphasise that the significant supply pressures on HRT go back to 2022 and there have been considerable improvements. To reiterate, we are talking about three products out of 70 and there are alternatives available. I encourage any woman who is concerned to speak to her GP or pharmacist to get the reassurance and the care she needs.

More from Baroness Merron (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.